Clinical Assessment Study of the HAnd (CASHA) - 6-year follow-up
- Conditions
- Musculoskeletal, All DiseasesMusculoskeletal DiseasesPolyarthrosis, unspecified
- Registration Number
- ISRCTN14121394
- Lead Sponsor
- Keele University (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 475
1. Existing member of the CAS-HA cohort
2. Responded to the 3-year Follow-up Health Questionnaire
3. Provided written informed consent to further contact at 3-year follow-up stage
4. Male & female participants
5. Lower Age Limit 50 years
1. Participants who have died since 3-year follow-up
2. Participants who have become vulnerable (e.g. participants with known new-onset dementia, serious/terminal pathology) since their baseline assessment as judged by the lead GP at each practice
3. Participants who have withdrawn consent to further contact following the 3-year follow-up
We are keen to avoid upsetting or burdening participants and their relatives whose circumstances may have changed. Prior to any contacts being made for 6-year follow-up we will check to ensure that the mailing list contains no participants who have died. This means checking the mailing list at each practice. We are also including a screen of the mailing list by the lead GP at each practice to identify and exclude those participants who have become vulnerable since the screen was last conducted.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Australian Canadian Hand Osteoarthritis Index (AUSCAN) measured at baseline
- Secondary Outcome Measures
Name Time Method 1. Anxiety and depression (HADS) measured at baseline<br>2. Current employment status measured at baseline<br>3. General health (SF-12) measured at baseline<br>4. Pain location (manikin) measured at baseline<br>5. Presence of hand pain and problems nodes, swelling, and participation restriction measured at baseline<br>6. Radiographic hand osteoarthrits (OA) measured at baseline<br>7. Radiographic knee OA measured at baseline<br>8. Symptom satisfaction measured at baseline